Cargando…

CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean

We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm(3) at baseline (interquartile...

Descripción completa

Detalles Bibliográficos
Autores principales: Luz, Paula M., Belaunzarán-Zamudio, Pablo F., Crabtree-Ramírez, Brenda, Caro-Vega, Yanink, Hoces, Daniel, Rebeiro, Peter F., Blevins, Meridith, Pape, Jean W., Cortes, Claudia P., Padgett, Denis, Cahn, Pedro, Veloso, Valdilea G., McGowan, Catherine C., Grinsztejn, Beatriz, Shepherd, Bryan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498272/
https://www.ncbi.nlm.nih.gov/pubmed/26180829
http://dx.doi.org/10.1093/ofid/ofv079
_version_ 1782380595360301056
author Luz, Paula M.
Belaunzarán-Zamudio, Pablo F.
Crabtree-Ramírez, Brenda
Caro-Vega, Yanink
Hoces, Daniel
Rebeiro, Peter F.
Blevins, Meridith
Pape, Jean W.
Cortes, Claudia P.
Padgett, Denis
Cahn, Pedro
Veloso, Valdilea G.
McGowan, Catherine C.
Grinsztejn, Beatriz
Shepherd, Bryan E.
author_facet Luz, Paula M.
Belaunzarán-Zamudio, Pablo F.
Crabtree-Ramírez, Brenda
Caro-Vega, Yanink
Hoces, Daniel
Rebeiro, Peter F.
Blevins, Meridith
Pape, Jean W.
Cortes, Claudia P.
Padgett, Denis
Cahn, Pedro
Veloso, Valdilea G.
McGowan, Catherine C.
Grinsztejn, Beatriz
Shepherd, Bryan E.
author_sort Luz, Paula M.
collection PubMed
description We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm(3) at baseline (interquartile range [IQR], 60–251) to 413 cells/mm(3) (IQR, 234–598) by year 5.
format Online
Article
Text
id pubmed-4498272
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44982722015-07-15 CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean Luz, Paula M. Belaunzarán-Zamudio, Pablo F. Crabtree-Ramírez, Brenda Caro-Vega, Yanink Hoces, Daniel Rebeiro, Peter F. Blevins, Meridith Pape, Jean W. Cortes, Claudia P. Padgett, Denis Cahn, Pedro Veloso, Valdilea G. McGowan, Catherine C. Grinsztejn, Beatriz Shepherd, Bryan E. Open Forum Infect Dis Brief Reports We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm(3) at baseline (interquartile range [IQR], 60–251) to 413 cells/mm(3) (IQR, 234–598) by year 5. Oxford University Press 2015-06-05 /pmc/articles/PMC4498272/ /pubmed/26180829 http://dx.doi.org/10.1093/ofid/ofv079 Text en © The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Brief Reports
Luz, Paula M.
Belaunzarán-Zamudio, Pablo F.
Crabtree-Ramírez, Brenda
Caro-Vega, Yanink
Hoces, Daniel
Rebeiro, Peter F.
Blevins, Meridith
Pape, Jean W.
Cortes, Claudia P.
Padgett, Denis
Cahn, Pedro
Veloso, Valdilea G.
McGowan, Catherine C.
Grinsztejn, Beatriz
Shepherd, Bryan E.
CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
title CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
title_full CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
title_fullStr CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
title_full_unstemmed CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
title_short CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
title_sort cd4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in latin america and the caribbean
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498272/
https://www.ncbi.nlm.nih.gov/pubmed/26180829
http://dx.doi.org/10.1093/ofid/ofv079
work_keys_str_mv AT luzpaulam cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT belaunzaranzamudiopablof cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT crabtreeramirezbrenda cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT carovegayanink cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT hocesdaniel cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT rebeiropeterf cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT blevinsmeridith cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT papejeanw cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT cortesclaudiap cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT padgettdenis cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT cahnpedro cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT velosovaldileag cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT mcgowancatherinec cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT grinsztejnbeatriz cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean
AT shepherdbryane cd4responseupto5yearsaftercombinationantiretroviraltherapyinhumanimmunodeficiencyvirusinfectedpatientsinlatinamericaandthecaribbean